Nxstage Medical, Inc. (NXTM) Tops Q2 EPS by 1c; Guides Wider Q3 Loss; Gets EU Approval for New Bolus Use
Go back to Nxstage Medical, Inc. (NXTM) Tops Q2 EPS by 1c; Guides Wider Q3 Loss; Gets EU Approval for New Bolus Use| NxStage Medical, Inc. (NASDAQ: NXTM) | Delayed: 30.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.00 | 52 Week High | $26.83 | |||
| Open | $94.18 | 52 Week Low | $13.49 | |||
| Day High | $30.00 | P/E | N/A | |||
| Day Low | $30.00 | EPS | $-0.26 | |||
| Volume | 0 | |||||
